We developed a novel breath sensor: No hard, forced breathing technique like peak flow meter required. Just breath in and out for individual breath monitoring.
⚕️⚕️⚕️⚕️⚕️⚕️
Our prototype #BreathEasyFlow has been successfully used in several clinical trials and has demonstrated equivalence to the Gold Standard hospital based Spirometry test in identifying changes in lung function.
⚕️⚕️⚕️⚕️⚕️⚕️
Our success - What others says:
"The device uses a novel approach based on the exhaled breath condensate breath profile and [...] data suggests [...] great value to the management of the asthma patient in the home"
Prof A. Wardlaw, Head of Respiratory Medicine, Leicester (2018)
What others says:
"[...] newer technologies [...] such as BreathEasyFlow have tremendous potential to inform initial diagnosis and ongoing self management, and support clinician decision making."
Dr. John Blakey, Former Respiratory Lead for the NIHR Clinical Research Network
Our success - What others says:
"[BreathEasyFlow is] a highly innovative and impactful solution... will add to the state of the art... complementary to the development of SMART inhaler devices already in the market..."
Biomedical Catalyst / InnovateUK, 2017
Prevalence of lung disease in Ireland was already high prior to Covid-19. David Lynch speaks to the Irish Thoracic Society President Dr Aidan O’Brien about the major impact the pandemic is having on respiratory care https://t.co/V4yzpPJZte
@irishthoracicS
#lungdisease